Haviv; Fortuna
Patent Applications and Registrations
Patent applications and USPTO patent grants for Haviv; Fortuna.The latest application filed is for "tetra-, penta-, hexa- and heptapeptides having antiangiogenic activity".
Company Profile
0.21.29
- Haviv; Fortuna - Deerfield IL
- Haviv; Fortuna - Rehovot IL
Patent Activity
| Patent | Date |
|---|---|
| Ureas having antiangiogenic activity Grant 7,592,466 - Haviv , et al. September 22, 2 | 2009-09-22 |
| Pharmaceutical formulation comprising a peptide angiogenesis inhibitor Grant 7,432,245 - Haviv , et al. October 7, 2 | 2008-10-07 |
| Tetra-, Penta-, Hexa- And Heptapeptides Having Antiangiogenic Activity App 20080071062 - Haviv; Fortuna ; et al. | 2008-03-20 |
| Hexa-, Hepta-, and Octapeptides Having Antiangiogenic Activity App 20070167376 - Haviv; Fortuna ; et al. | 2007-07-19 |
| Method Of Inhibiting Angiogenesis App 20070043089 - HAVIV; FORTUNA ; et al. | 2007-02-22 |
| Method Of Inhibiting Angiogenesis App 20070032527 - Haviv; Fortuna ; et al. | 2007-02-08 |
| Tetra-, penta-, hexa- and heptapeptides having antiangiogenic activity Grant 7,169,888 - Haviv , et al. January 30, 2 | 2007-01-30 |
| Hexa-, hepta-, and octapeptides having antiangiogenic activity Grant 7,122,625 - Haviv , et al. October 17, 2 | 2006-10-17 |
| Hepta-, octa-and nonapeptides having antiangiogenic activity App 20060194737 - Haviv; Fortuna ; et al. | 2006-08-31 |
| Ureas having antiangiogenic activity App 20060160806 - Haviv; Fortuna ; et al. | 2006-07-20 |
| Hepta-, Octa-and nonapeptides having antiangiogenic activity Grant 7,067,490 - Haviv , et al. June 27, 2 | 2006-06-27 |
| TRI-, TETRA-, and penta-peptides having antiangiogenic activity Grant 7,037,897 - Haviv , et al. May 2, 2 | 2006-05-02 |
| Di-, tri-, and tetra-peptides having antiangiogenic activity Grant 7,001,984 - Haviv , et al. February 21, 2 | 2006-02-21 |
| Substituted pyridines having antiangiogenic activity App 20060030557 - Haviv; Fortuna ; et al. | 2006-02-09 |
| Di-, tri-, and tetra-peptides having antiangiogenic activity App 20050215484 - Haviv, Fortuna ; et al. | 2005-09-29 |
| Peptide antiangiogenic drugs App 20050124548 - Henkin, Jack ; et al. | 2005-06-09 |
| N-alkylated peptides having antiangiogenic activity Grant 6,777,535 - Haviv , et al. August 17, 2 | 2004-08-17 |
| Peptide antiangiogenic drugs Grant 6,774,211 - Henkin , et al. August 10, 2 | 2004-08-10 |
| Peptides having antiangiogenic activity Grant 6,753,408 - Haviv , et al. June 22, 2 | 2004-06-22 |
| Method of inhibiting angiogenesis App 20040116479 - Haviv, Fortuna ; et al. | 2004-06-17 |
| Method of inhibiting angiogenesis App 20040067985 - Haviv, Fortuna ; et al. | 2004-04-08 |
| Peptide antiangiogenic drugs Grant 6,716,963 - Henkin , et al. April 6, 2 | 2004-04-06 |
| Substituted pyridines having antiangiogenic activity App 20040014744 - Haviv, Fortuna ; et al. | 2004-01-22 |
| Pharmaceutical formulation App 20030229022 - Haviv, Fortuna ; et al. | 2003-12-11 |
| Pharmaceutical formulation App 20030228365 - Haviv, Fortuna ; et al. | 2003-12-11 |
| Nicotinamides having antiangiogenic activity App 20030195192 - Haviv, Fortuna ; et al. | 2003-10-16 |
| Substituted pyridines having antiangiogenic activity App 20030195195 - Haviv, Fortuna ; et al. | 2003-10-16 |
| Penta- and hexapeptides having antiangiogenic activity App 20030125261 - Haviv, Fortuna ; et al. | 2003-07-03 |
| Tetra-and pentapeptides having antiangiogenic activity App 20030125260 - Haviv, Fortuna ; et al. | 2003-07-03 |
| Octa- and nonapeptides having antiangiogenic activity App 20030125259 - Haviv, Fortuna ; et al. | 2003-07-03 |
| HEXA- and heptapeptides having antiangiogenic activity App 20030119745 - Haviv, Fortuna ; et al. | 2003-06-26 |
| Hepta-and octapeptides having antiangiogenic activity App 20030119746 - Haviv, Fortuna ; et al. | 2003-06-26 |
| Hexa-, hepta-, and octapeptides having antiangiogenic activity App 20030114386 - Haviv, Fortuna ; et al. | 2003-06-19 |
| Tetra-, penta-, hexa- and heptapeptides having antiangiogenic activity App 20030105022 - Haviv, Fortuna ; et al. | 2003-06-05 |
| Tri-and tetrapeptides having antiangiogenic activity App 20030105025 - Haviv, Fortuna ; et al. | 2003-06-05 |
| Tetra-, penta-, hexa- and heptapeptides having antiangiogenic activity App 20030105023 - Haviv, Fortuna ; et al. | 2003-06-05 |
| HEPTA-, OCTA- and nonapeptides having antiangiogenic activity App 20030096758 - Haviv, Fortuna ; et al. | 2003-05-22 |
| Peptides having antiangiogenic activity App 20030050246 - Haviv, Fortuna ; et al. | 2003-03-13 |
| Peptides having antiangiogenic activity App 20030045477 - Haviv, Fortuna ; et al. | 2003-03-06 |
| Peptide antiangiogenic drugs App 20020183242 - Henkin, Jack ; et al. | 2002-12-05 |
| Macrolide LHRH antagonists Grant 6,020,521 - Randolph , et al. February 1, 2 | 2000-02-01 |
| Tetrahydroisoquinoline derivatives as LHRH antagonists Grant 5,981,521 - Haviv , et al. November 9, 1 | 1999-11-09 |
| LHRH antagonists having lactam groups at the N-terminus Grant 5,516,759 - Swenson , et al. May 14, 1 | 1996-05-14 |
| Cyclic peptide LHRH antagonists Grant 5,508,383 - Sauer , et al. April 16, 1 | 1996-04-16 |
| N-terminus modified analogs of LHRH Grant 5,502,035 - Haviv , et al. March 26, 1 | 1996-03-26 |
| N-terminus modified analogs of LHRH Grant 5,413,990 - Haviv , et al. May 9, 1 | 1995-05-09 |
| Octapeptide LHRH antagonists Grant 5,140,009 - Haviv , et al. August 18, 1 | 1992-08-18 |
| LHRH analogs Grant 5,110,904 - Haviv , et al. May 5, 1 | 1992-05-05 |
| [1-(2-Benzoxazolyl)hydrazino]alkyl nitrile derivatives Grant 4,476,137 - Haviv , et al. October 9, 1 | 1984-10-09 |
| Isothiourea substituted cephalosporin derivatives Grant 3,948,904 - Patchornik , et al. April 6, 1 | 1976-04-06 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 